PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 27409171-5 2016 In addition, the mean serum NSE level was lower in the CR group than in the non-CR group. Chromium 55-57 enolase 2 Homo sapiens 28-31 31978453-7 2020 The NSE was associated with a pooled sensitivity of 0.56 (95% credible interval [CrI], 0.47-0.65) and pooled specificity of 0.99 (95% CrI, 0.98-1.00). Chromium 81-84 enolase 2 Homo sapiens 4-7 31978453-7 2020 The NSE was associated with a pooled sensitivity of 0.56 (95% credible interval [CrI], 0.47-0.65) and pooled specificity of 0.99 (95% CrI, 0.98-1.00). Chromium 134-137 enolase 2 Homo sapiens 4-7 27409171-5 2016 In addition, the mean serum NSE level was lower in the CR group than in the non-CR group. Chromium 80-82 enolase 2 Homo sapiens 28-31 20537424-7 2011 The rate of CR to salvage chemotherapy was significantly lower in patients with elevated levels of NSE (2.2%) than in patients without (26.7%; p=0.001). Chromium 12-14 enolase 2 Homo sapiens 99-102 8616474-4 1995 Complete remission (CR) was observed only in patients with limited disease and in those in whom NSE serum level was below 50 ng/l. Chromium 20-22 enolase 2 Homo sapiens 96-99 11282430-6 2001 In the SCLC patients receiving chemotherapy, the CR rate in patients with elevated NSE levels was significantly lower than in patients with normal levels of NSE (18.5 vs. 61.7%, P < 0.001). Chromium 49-51 enolase 2 Homo sapiens 83-86 11282430-6 2001 In the SCLC patients receiving chemotherapy, the CR rate in patients with elevated NSE levels was significantly lower than in patients with normal levels of NSE (18.5 vs. 61.7%, P < 0.001). Chromium 49-51 enolase 2 Homo sapiens 157-160